Literature DB >> 32890756

Which Are the Optimal Criteria for the Diagnosis of Allergic Bronchopulmonary Aspergillosis? A Latent Class Analysis.

Puneet Saxena1, Hansraj Choudhary2, Valliappan Muthu1, Inderpaul Singh Sehgal1, Sahajal Dhooria1, Kuruswamy Thurai Prasad1, Mandeep Garg3, Biman Saikia4, Ashutosh Nath Aggarwal1, Arunaloke Chakrabarti2, Ritesh Agarwal5.   

Abstract

BACKGROUND: The ideal criteria for diagnosing allergic bronchopulmonary aspergillosis (ABPA) remain unknown because of the lack of a criterion standard. Latent class analysis using a probabilistic modeling technique can circumvent the need for a reference standard.
OBJECTIVE: To compare the diagnostic performance of various criteria used for evaluating ABPA.
METHODS: We prospectively enrolled consecutive cases of bronchial asthma and performed a series of investigations used for the diagnosis of ABPA. We used latent class analysis to analyze the performance of various existing and novel diagnostic criteria.
RESULTS: Of the 543 subjects (mean age, 37 years; 319 women), 338 (62.2%) and 205 (37.8%) were labeled as "mild-to-moderate" and "severe" asthma cases, respectively. The subjects with severe asthma had a longer duration of asthma and a higher number of exacerbations in the previous year. The prevalence of Aspergillus fumigatus sensitization was 41% and 30%, using the A fumigatus-specific IgE and skin test, respectively. The prevalence of ABPA was 16%, using both the Rosenberg-Patterson and the International Society for Human and Animal Mycology (ISHAM)-ABPA Working Group criteria. The ISHAM criteria were slightly more sensitive (89% vs 81%) and specific (99% vs 98%) than the Patterson criteria. We obtained optimal diagnostic performance by altering the existing ISHAM criteria (serum total IgE >500 international units/mL, excluding the skin test, and using computed tomography of thorax instead of chest radiograph).
CONCLUSIONS: The ISHAM-ABPA Working Group criteria were only marginally better than the Patterson criteria in diagnosing ABPA among patients with asthma younger than 66 years. The diagnostic performance however improved by modifying the prevailing ISHAM criteria, but with increased cost.
Copyright © 2020 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ABPA; Allergic bronchopulmonary mycosis; Allergy; Aspergillus; Asthma; Latent class analysis

Mesh:

Substances:

Year:  2020        PMID: 32890756     DOI: 10.1016/j.jaip.2020.08.043

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


  9 in total

Review 1.  The immune response to airway mycosis.

Authors:  Evan Li; Antony Rodriguez; Amber U Luong; David Allen; John Morgan Knight; Farrah Kheradmand; David B Corry
Journal:  Curr Opin Microbiol       Date:  2021-05-27       Impact factor: 7.584

Review 2.  Update on Respiratory Fungal Infections in Cystic Fibrosis Lung Disease and after Lung Transplantation.

Authors:  Sabine Renner; Edith Nachbaur; Peter Jaksch; Eleonora Dehlink
Journal:  J Fungi (Basel)       Date:  2020-12-21

Review 3.  Review of current and future therapeutics in ABPA.

Authors:  Elisa Lewington-Gower; Ley Chan; Anand Shah
Journal:  Ther Adv Chronic Dis       Date:  2021-10-23       Impact factor: 5.091

4.  Use of Intravenous Pulse Steroids to Treat Allergic Bronchopulmonary Aspergillosis in a Non-Compliant Asthmatic Adolescent.

Authors:  Sara G Hamad; Mutasim Abu-Hasan; Atqah AbdulWahab
Journal:  Children (Basel)       Date:  2022-02-14

5.  Evaluation of Simpler Criteria for Diagnosing Allergic Bronchopulmonary Aspergillosis Complicating Asthma.

Authors:  Ritesh Agarwal; Puneet Saxena; Valliappan Muthu; Inderpaul Singh Sehgal; Sahajal Dhooria; Kuruswamy Thurai Prasad; Ashutosh Nath Aggarwal; Arunaloke Chakrabarti
Journal:  Front Cell Infect Microbiol       Date:  2022-03-25       Impact factor: 5.293

6.  Allergic bronchopulmonary aspergillosis (ABPA) in an atopic patient with difficult-to-expectorate airway secretions.

Authors:  Marcus Joest
Journal:  Allergol Select       Date:  2021-05-27

Review 7.  Allergic fungal airways disease (AFAD): an under-recognised asthma endotype.

Authors:  Catherine H Pashley; Andrew J Wardlaw
Journal:  Mycopathologia       Date:  2021-05-27       Impact factor: 2.574

8.  Diagnosis of allergic bronchopulmonary aspergillosis in patients with persistent allergic asthma using three different diagnostic algorithms.

Authors:  Vida Mortezaee; Seyed Alireza Mahdaviani; Mihan Pourabdollah; Maryam Hassanzad; Maryam Sadat Mirenayat; Payam Mehrian; Naser Behnampour; Jamshid Yazdani Charati; Zahra Peirovi; Somayeh Sharifynia; Seyedmojtaba Seyedmousavi; Mohammad T Hedayati
Journal:  Mycoses       Date:  2020-12-08       Impact factor: 4.931

9.  Total unilateral pulmonary collapse secondary to allergic bronchopulmonary aspergillosis: a case series of an unusual cause of complete atelectasis.

Authors:  N Benkalfate; S Dirou; P Germaud; C Defrance; A Cavailles; T Pigeanne; M Robert; T Madjer; F Corne; L Cellerin; C Sagan; F X Blanc
Journal:  BMC Pulm Med       Date:  2021-12-24       Impact factor: 3.317

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.